Active is: Investing with conviction

Expect US market momentum to continue – but watch for inflation

15/01/2021
Expect US market momentum to continue – but watch for inflation

Summary

Investors can start the year with a positive outlook for the markets thanks to three drivers: higher spending from the new Biden administration, wider uptake of vaccines and continued Fed support. Consider layering in exposure to value and cyclical stocks, small cap and international assets – but keep an eye on rising inflation.

Key takeaways

  • We expect economic growth in the US and globally to reaccelerate in 2021 – a positive sign for many risk assets, but it may push inflation higher over time
  • The Biden administration will prioritise putting money into the hands of consumers and back into the economy – which will likely support value and cyclical sectors broadly
  • Successful vaccine distribution could release pent-up consumer demand – particularly in areas (such as travel and leisure) that stand to benefit as the economy reopens

US markets have largely shrugged off the political volatility of the new year, continuing the momentum with which they ended 2020. Looking at different market sectors, value stocks continue to largely outperform growth stocks, and small caps are playing catch-up to large caps. At the same time, international and emerging-market equities are outpacing their US counterparts, driven by ongoing US dollar weakness, the prospects for stronger global growth and generally better valuations.

The financial markets are also counting on additional fiscal and monetary stimulus in 2021, as indicated by the Biden administration and the US Federal Reserve, even as economic growth has already started to rebound. Against this backdrop, investors can start the new year with a positive outlook for the markets. Investors may want to tactically add to or diversify risk in portfolios, but it will be important to be vigilant as the year progresses – including watching for higher inflation down the road.

Three factors driving renewed momentum in the market shift towards value stocks

The Democrats’ “blue sweep” became reality

Following the US election results in November, it appeared likely that incoming President Joe Biden would face a “divided” US Congress and gridlock in the US government, putting most of his agenda in peril. But the resolution of Georgia’s Senate races ultimately ceded control of both the House and Senate to the Democrats, although they still have only slim majorities. That makes a “Biden-lite” agenda likely: for example, tax increases will be less than initially outlined and may not be a year-one priority. Instead, we expect the new administration to first pursue policy items that have more bipartisan support from both Democrats and Republicans, such as stimulus packages and fiscal spending:

  • Covid-19 stimulus in the range of USD 1 trillion could be passed in the first 100 days of a Biden administration – including USD 2,000 stimulus cheques (meant to put money directly into the hands of consumers) and support for state and local governments. This should be positive for value cyclical sectors tied to the economic recovery.
  • Fiscal spending in areas such as infrastructure is attractive to both Democrats and Republicans. Expect a proposed infrastructure-spending package of under USD 1 trillion. This would include traditional infrastructure as well as areas such as renewable energy and technology (including 5G and broadband).
  • Although clean-energy spending is unlikely to hit the Biden team’s original USD 2 trillion goal, they may still seek meaningful subsidies for wind and solar power and electric vehicles. And Mr Biden is committed to returning the US to the Paris Climate Accord.
  • Other agenda items that could have bipartisan support include cutting drug prices and reining in “Big Tech”. These are important issues for the markets, but they are not necessarily a high priority for the Biden administration. For now, we expect incremental change rather than wholesale shifts in these industries.

Vaccines are finally here, despite the slow rollout

Stimulus is certainly a helpful bridge for consumers and small businesses, but as long as the pandemic is ongoing, economic activity is likely to remain depressed. Fortunately, vaccine distribution has begun in the US and globally. If it’s effective, the subsequent economic reopening will likely be the biggest market driver in the US and globally in 2021.

In such a scenario, we expect pent-up consumer demand to be unleashed – particularly in sectors such as travel and leisure that would benefit from the reopening economy. This is already reflected in strong economic and earnings forecasts, as Chart 1 shows, although they could move higher in future earnings revisions if more progress is made fighting the pandemic.

So far, however, the US rollout of the vaccines has been slower than anticipated. But this may turn around based on a few factors: states will learn how to make distribution more effective; the Biden administration will focus on increasing the number of doses available; and new vaccines from other companies should reduce supply constraints.

Barring any severe shocks or setbacks – including new variants of the virus – 2021 is likely to be a year of reaccelerating economic growth. For investors, this may mean that a bear-market selloff, which often occurs ahead of recessions, appears unlikely in the near term. As a result, market corrections could largely be used as tactical buying opportunities.

Chart 1: earnings growth is set to reaccelerate in 2021

S&P 500 earnings growth by quarter (year over year)

Chart 1: earnings growth is set to reaccelerate in 2021

Source: FactSet, Allianz Global Investors. Data as at January 2021.

The Fed will continue to support markets in 2021

In its final meeting of 2020, the Fed released an updated set of economic projections (see Chart 2). Through 2023, rates are expected to remain near zero and inflation below the US central bank’s 2.0% target. Growth and unemployment expectations were also upgraded, and the Fed is committed to maintaining its monthly asset purchases. This will continue to expand the Fed’s balance sheet and provide liquidity to markets.

Overall, central banks in the US and around the world continue to provide strong support for risk assets against what was already expected to be a recovery year.

Chart 2: the Fed expects near-zero rates through 2023, and an improving growth and unemployment outlook

Chart 2: the Fed expects near-zero rates through 2023, and an improving growth and unemployment outlook

Source: Federal Open Market Committee. Data as at December 2020.

While keeping this positive outlook in mind, watch for inflationary pressures

While the economic and market outlook for 2021 is solid, there are some accompanying risks. One is that rebounding growth and stimulus could push up the prices of goods and services – driving up inflationary pressures. So far, inflation has been relatively contained, with core PCE – personal consumption expenditures, the Fed’s preferred indicator – still below the Fed’s 2.0% target. However, some forward-looking indicators (which measure the market’s inflation expectations) call for higher inflation, as Chart 3 shows.

Chart 3: core PCE remains below the Fed’s 2.0% target, but the inflation outlook is rising

Chart 3: core PCE remains below the Fed’s 2.0% target, but the inflation outlook is rising

Source: Bloomberg, Allianz Global Investors. Data as at 11 January 2021. The 5-year/5-year swap is a measurement of medium-term inflation expectations. Low numbers indicate that the markets are doubtful about a central bank’s ability to push inflation higher.

If inflation does accelerate, we see three key risks for investors:

  • The Fed is now targeting an average inflation rate regime – meaning it will tolerate a period of higher-than-2.0% inflation without raising rates. But a sustained or rapid rise in inflation may cause the Fed to rethink its approach. Historically, bear markets have begun when Fed rate-hike cycles are on the horizon.
  • If higher inflation leads to higher yields, longer-duration assets could suffer. These include certain government and corporate bonds, but also some sectors like technology and healthcare, which tend to be longer duration and could be punished by markets that fear higher inflation.
  • Given that some stock valuations may already be stretched, particularly in certain growth areas, higher inflation and higher yields could push down these valuations over time.

Consider tactical shifts towards cyclicals and emerging markets

The global economy is recovering – in part thanks to “reflation” policies, such as fiscal stimulus and low rates, designed to boost demand and spending – and we expect it to enter a true reopening period later this year.

As such, we expect markets will continue to favour the reflation theme – but for how long? Perhaps until the economy either reaches peak reopening growth rates or enters a sustained period of inflation, which makes slowing growth or mounting inflationary pressures key indicators to watch.

Given such strong upwards movement already, periods of consolidation or market pullbacks should be expected in the weeks ahead. But investors can largely use these as tactical opportunities to add to or diversify risk. Consider adding incremental exposure by “layering in” cyclical and value stocks, small-cap stocks and non-US assets. Select areas of infrastructure, 5G technology and clean energy may also continue to do well in a post-election world.

In fixed income, prepare for somewhat higher rates and steeper yield curves. Long rates (which are generally determined by market forces) may rise alongside growth and inflation expectations, while short rates remain anchored by central banks. More stimulus could also mean a marginally weaker US dollar, which would continue to benefit emerging-market assets, gold and those industrial commodities (including copper) that are tied to the reopening.

1474317

Active is: Inventing new opportunities

China reaches for the STAR market

20/01/2021
Old building in China

Summary

China’s nascent STAR market provides a platform for the technology and science firms that increasingly underpin the country’s growth story.

Key takeaways

  • China’s new STAR market has been billed as the country’s answer to the Nasdaq – the technology-focused US exchange
  • Its listing rules make it easier for the country’s tech and science startups to list domestically, thereby supporting the fast-growing sectors that are driving China’s growth
  • Since opening in July 2019 with 25 listings, the STAR market now comprises almost 200 firms – and nearly 500 are in the IPO pipeline.

Allianz Global Investors

You are leaving this website and being re-directed to the below website outside Singapore. This does not imply any approval or endorsement of the information by Allianz Global Investors Singapore Limited contained in the redirected website nor does Allianz Global Investors Singapore Limited accept any responsibility or liability in connection with this hyperlink and the information contained herein. Please keep in mind that the redirected website may contains funds and strategies not authorized for offering to the public of Singapore. Besides, please also take note on the redirected website’s terms and conditions, privacy and security policies, or other legal information. By clicking “Continue”, you confirm you acknowledge the details mentioned above and would like to continue accessing the redirected website. Please click “Stay here” if you have any concerns.

Welcome to Allianz Global Investors

Select your role
  • Individual Investor
  • Intermediaries
  • Institutional Investor
  • It contains legal and regulatory notices relevant to the information contained on this website. By accessing this website, you agree to be bound by the following terms and conditions. Please discontinue your access to this website immediately if you do not accept any of these terms or conditions.


    Investments

    The content of this website is for informational purposes only and does not have any regard to the specific investment objectives, financial situation or particular needs of any particular person.

    Advice should be sought from a financial adviser regarding the suitability of any fund before purchasing units in the fund. In the event that you choose not to seek advice from a financial adviser, you should consider whether the fund is suitable for you. Prices of funds and income from them may fall or rise and cannot be guaranteed.

    Past performance of any fund or manager/ sub-manager of the fund are not necessarily indicative of future performance.

    Prospectuses for funds registered with the Monetary Authority of Singapore under the Authorised Scheme and Recognised Scheme are available, and may be obtained from Allianz Global Investors Singapore Limited or its appointed distributors. Investors should read the prospectuses before investing in such funds.


    No Reliance

    Although Allianz Global Investors Singapore Limited has taken all reasonable care that the information contained within the website is accurate at the time of publication, no representation or warranty (including liability towards third parties), expressed or implied, is made as to its accuracy, reliability or completeness by Allianz Global Investors Singapore Limited or its contractual partners.

    Opinions and any other contents on this website are provided by Allianz Global Investors Singapore Limited for personal use and informational purposes only and are subject to change without notice.

    Nothing contained in the website constitutes investment, legal, tax or other advice nor is to be relied on in making an investment or other decision. You should obtain relevant and specific professional advice before making any investment decision.


    No Warranty

    The information and opinions contained on the website are provided without any warranty of any kind, either expressed or implied, to the fullest extent pursuant to applicable law. Allianz Global Investors Singapore Limited further assumes no responsibility for, and makes no warranties that, functions contained on the website will be uninterrupted or error-free, that defects will be corrected, or that the website or the servers that make it available will be free of viruses or other harmful components.


    Liability Waiver

    Under no circumstances, including , but not limited to, negligence, shall Allianz Global Investors Singapore Limited be liable for any special or consequential damages that result from the access or use of, or the inability to access or use, the materials at the website.


    Linked Sites

    Allianz Global Investors Singapore Limited has not reviewed any websites which link to this website, and is not responsible for the contents of off-site pages linked to from this website or any other websites linked to this website. Following links to any off-site pages or other websites shall be entirely at your own risk.

    The only exception to the above is that Allianz Global Investors Singapore Limited will ensure that all our electronic prospectuses comply with the requirements for electronic prospectuses set out in the Guidelines on Offer of Securities made through the Internet issued by the Monetary Authority of Singapore.


    Copyright

    Copyright to this website is owned by Allianz Global Investors Singapore Limited. The copyrights of third parties are reserved. You may download or print a hard copy of individual pages and/or sections of the website, provided that you do not remove any copyright or other proprietary notices. Any downloading or other copying from the website will not transfer title of any software or material to you. You may not reproduce (in whole or part), transmit (by electronic means or otherwise), modify, hyperlink or use for any public or commercial purpose the website without the prior permission of Allianz Global Investors Singapore Limited.

    All trademarks, service marks and logos on this website are the property of Allianz Global Investors Singapore Limited and other third party proprietors where applicable. Nothing on this website shall be construed as granting any license or right to use any image, trademark, service mark or logo, and Allianz Global Investors Singapore Limited will enforce such rights to the full extent of applicable law.


    Money Laundering

    As a result of money laundering and other regulations, additional documentation for identification purposes may be required when you make your investment.


    Governing Law and Jurisdiction

    These Terms and Conditions governing Allianz Global Investors Singapore Limited's website shall be governed by and construed in accordance with the laws of the Republic of Singapore. By accessing this website's online services, you agree that in relation to any legal action or proceedings arising out of or in connection with these said terms and conditions, you hereby irrevocably submit to the jurisdiction of the courts of the Republic of Singapore.

    Approved for issue by Allianz Global Investors Singapore Limited, 79 Robinson Road, #09-03, Singapore 068897. Company Regn. No. 199907169Z.

    You may face minimal or no returns or suffer total loss of their investments if both the guarantor and the note issuer default.

     

Please indicate you have read and understood the Important Notice.